INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

Shares of Inovio Pharmaceuticals Inc. INO slipped 2.91% to $4.01 Tuesday, on what proved to be an all-around favorable ...

Inovalis Real Estate Investment Trust (the "REIT") (TSX: INO.UN) today announced the signing of an exchange contract for the sale of the Sablière property to a third party for €18.2 million ($26.4 ...

Merck & Co. Inc. 1.48% $257.06B ...

Huayou and Vale seek funding for a major nickel smelter project. Read why nickel's future looks strong with key partnerships ...

Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After hours: 20 November at 18:46 GMT-5 ...